Zacks: Brokerages Set $65.00 Target Price for U.S. Physical Therapy Inc. (NYSE:USPH)
Shares of U.S. Physical Therapy Inc. (NYSE:USPH) have received a consensus broker rating score of 3.00 (Hold) from the two analysts that provide coverage for the company, Zacks Investment Research reports. Two research analysts have rated the stock with a hold recommendation. U.S. Physical Therapy’s rating score has declined by 50% from three months ago as a result of a number of analysts’ upgrades and downgrades.
Brokers have set a 12 month consensus price objective of $65.00 for the company and are anticipating that the company will post $0.49 EPS for the current quarter, according to Zacks. Zacks has also assigned U.S. Physical Therapy an industry rank of 204 out of 265 based on the ratings given to related companies.
Several analysts recently issued reports on USPH shares. Zacks Investment Research lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research report on Wednesday, August 3rd. Barrington Research downgraded shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research note on Friday, August 5th. Finally, Jefferies Group set a $65.00 price objective on shares of U.S. Physical Therapy and gave the stock a “hold” rating in a research report on Friday, August 5th.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/zacks-brokerages-set-65-00-target-price-for-u-s-physical-therapy-inc-nyseusph.html
U.S. Physical Therapy (NYSE:USPH) traded down 2.62% during midday trading on Wednesday, reaching $61.98. The company had a trading volume of 93,743 shares. The stock’s 50 day moving average price is $62.31 and its 200-day moving average price is $56.88. The firm has a market capitalization of $775.99 million, a P/E ratio of 31.95 and a beta of 0.76. U.S. Physical Therapy has a one year low of $42.59 and a one year high of $64.89.
U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Thursday, August 4th. The company reported $0.57 EPS for the quarter, beating the Zacks’ consensus estimate of $0.55 by $0.02. U.S. Physical Therapy had a net margin of 6.95% and a return on equity of 12.06%. The business had revenue of $90.40 million for the quarter, compared to analyst estimates of $90.01 million. During the same quarter in the prior year, the business earned $0.51 EPS. U.S. Physical Therapy’s quarterly revenue was up 8.5% on a year-over-year basis. On average, equities research analysts anticipate that U.S. Physical Therapy will post $1.99 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 2nd. Stockholders of record on Friday, August 19th were given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.07%. The ex-dividend date was Wednesday, August 17th. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 34.87%.
In other U.S. Physical Therapy news, CEO Christopher J. Reading sold 8,000 shares of the firm’s stock in a transaction on Monday, September 19th. The shares were sold at an average price of $64.01, for a total value of $512,080.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Lawrance W. Mcafee sold 2,000 shares of the firm’s stock in a transaction on Friday, August 5th. The stock was sold at an average price of $59.60, for a total transaction of $119,200.00. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.
Large investors have recently bought and sold shares of the company. Prudential Financial Inc. raised its stake in U.S. Physical Therapy by 9.8% in the first quarter. Prudential Financial Inc. now owns 31,870 shares of the company’s stock valued at $1,585,000 after buying an additional 2,850 shares during the period. BlackRock Institutional Trust Company N.A. raised its stake in U.S. Physical Therapy by 1.1% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 335,842 shares of the company’s stock valued at $16,701,000 after buying an additional 3,592 shares during the period. Huntington Asset Advisors Inc. purchased a new position in shares of U.S. Physical Therapy during the first quarter valued at approximately $221,000. UBS Group AG boosted its position in shares of U.S. Physical Therapy by 1.5% in the first quarter. UBS Group AG now owns 31,384 shares of the company’s stock valued at $1,561,000 after buying an additional 455 shares in the last quarter. Finally, UBS Asset Management Americas Inc. boosted its position in shares of U.S. Physical Therapy by 8.5% in the first quarter. UBS Asset Management Americas Inc. now owns 6,077 shares of the company’s stock valued at $302,000 after buying an additional 478 shares in the last quarter. Institutional investors and hedge funds own 98.33% of the company’s stock.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.